Ondine Biomedical Inc
LSE:OBI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8
18
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Relative Value
The Relative Value of one OBI stock under the Base Case scenario is 10.08 GBX. Compared to the current market price of 8 GBX, Ondine Biomedical Inc is Undervalued by 21%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
OBI Competitors Multiples
Ondine Biomedical Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
O
|
Ondine Biomedical Inc
LSE:OBI
|
41.5m GBP | 0.3 | -0 | 0 | 0 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
211.7B USD | 4.8 | 15.1 | 19.3 | 26.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
191.8B USD | 20 | 69.8 | 53.4 | 65.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.1B USD | 5.7 | 47.3 | 23 | 27.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
130.5B USD | 6.7 | 46.8 | 27.5 | 37.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124B USD | 3.6 | 26 | 14.7 | 21.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.1B USD | 2.7 | 35.2 | 12.9 | 21.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.6B EUR | 2.1 | 23.1 | 13.1 | 18.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
57.2B USD | 13.7 | 55.7 | 40 | 44.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49B USD | 8.3 | 35.8 | 25.6 | 28 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.6B USD | 7.2 | 26.1 | 18.7 | 20.8 |
